Sweden: Eir Ventures I life sciences VC fund closes at €122.3m

By
Nick Herbert
-

Eir Ventures, a Nordic Life Science Venture Capital manager, has closed Eir Ventures I at €122.3m (US$137.8m) . The fund is the firm’s first dedicated life sciences venture capital fund. It was launched in 2020 with support from a syndicate comprising the European Investment Fund (EIF), Novo Holdings, Saminvest, Vækstfonden, as well as a group…

Membership Required

You must be a HMI Subscriber to view this content.

Subscribe Now »

Already have an account?
Previous articleNo further forward
Next articlePart of the solution
Nick Herbert
Nick Herbert
Nick Herbert has over 30 years’ experience in the financial markets, as both a practitioner and journalist. He started work as an investment banker in London, before joining International Financing Review (IFR) to report on debt capital markets and derivatives. He moved to Singapore in 2000 to manage IFR’s financial markets editorial team throughout Asia, before returning to London in 2009 to take up the position of Publisher for Reuters Capital Markets Publications. For the last five years he has been covering global capital markets, ESG finance and healthcare markets on a freelance basis.
Linkedin